Involvement of the HERV-derived cell-fusion inhibitor, suppressyn, in the fusion defects characteristic of the trisomy 21 placenta
Abstract Suppressyn (SUPYN) is the first host-cell encoded mammalian protein shown to inhibit cell–cell fusion. Its expression is restricted to the placenta, where it negatively regulates syncytia formation in villi. Since its chromosomal localization overlaps with the Down syndrome critical region...
Main Authors: | Jun Sugimoto, Danny J. Schust, Tomomi Yamazaki, Yoshiki Kudo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-14104-1 |
Similar Items
-
Controlling Trophoblast Cell Fusion in the Human Placenta—Transcriptional Regulation of Suppressyn, an Endogenous Inhibitor of Syncytin-1
by: Jun Sugimoto, et al.
Published: (2023-11-01) -
Could the Human Endogenous Retrovirus-Derived Syncytialization Inhibitor, Suppressyn, Limit Heterotypic Cell Fusion Events in the Decidua?
by: Jun Sugimoto, et al.
Published: (2021-09-01) -
Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta
by: Jean Guibourdenche, et al.
Published: (2023-04-01) -
Integrative analyses of genes and microRNA expressions in human trisomy 21 placentas
by: Ji Hyae Lim, et al.
Published: (2018-05-01) -
Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid Leukemia
by: Jiaxin Shen, et al.
Published: (2024-01-01)